Peritoneal carcinomatosis (PC) from colorectal carcinoma research hub

A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy

This study is looking at a new treatment for bowel cancer that has spread to the lining of the tummy. It's an early-stage trial checking if the treatment is safe, how much to give, and if it helps after a type of surgery and chemotherapy.